CSL's business activities include CSL Behring, CSL Bioplasma, CSL Biotherapies and our global research and development operations.
CSL Behring Report
CSL Bioplasma Report
CSL Biotherapies Report
New Product Development Report
See also Business Features
Back | Next
|
 |
| In September 2006, CSL announced that most of our Research Group would be relocating to the Bio21 Institute at Melbourne University. Among the guests at a function to mark this event were CSL Chairman, Elizabeth Alexander, CSL's Chief Executive Officer and Managing Director, Dr Brian McNamee (left), and our Chief Scientific Officer, Dr Andrew Cuthbertson. | |
